Correction: Small molecule induces mitochondrial fusion for neuroprotection via targeting CK2 without affecting its conventional kinase activity

Ke-Wu Zeng,Jing-Kang Wang,Li-Chao Wang,Qiang Guo,Ting-Ting Liu,Fu-Jiang Wang,Na Feng,Xiao-Wen Zhang,Li-Xi Liao,Mei-Mei Zhao,Dan Liu,Yong Jiang,Pengfei Tu
DOI: https://doi.org/10.1038/s41392-021-00533-3
IF: 39.3
2021-03-12
Signal Transduction and Targeted Therapy
Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41392-021-00533-3
biochemistry & molecular biology,cell biology
What problem does this paper attempt to address?
The main purpose of this paper is to study how a small molecule can induce mitochondrial fusion by targeting CK2 (protein kinase C2) to achieve neuroprotective effects, without affecting the traditional kinase activity of CK2. Specifically, the researchers found that this small molecule can exert neuroprotective effects in a small model organism, zebrafish, under ischemia/reperfusion injury. By analyzing experimental data such as zebrafish swimming performance, the effectiveness and potential therapeutic value of this small molecule were demonstrated.